NO20042061L - Gonadotropiner for folliculogenesis - Google Patents

Gonadotropiner for folliculogenesis

Info

Publication number
NO20042061L
NO20042061L NO20042061A NO20042061A NO20042061L NO 20042061 L NO20042061 L NO 20042061L NO 20042061 A NO20042061 A NO 20042061A NO 20042061 A NO20042061 A NO 20042061A NO 20042061 L NO20042061 L NO 20042061L
Authority
NO
Norway
Prior art keywords
folliculogenesis
gonadotropins
sialysis
provides
high degree
Prior art date
Application number
NO20042061A
Other languages
English (en)
Other versions
NO327966B1 (no
Inventor
Ernest Loumaye
Carlo Emanuele Giartosio
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23323355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042061(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20042061L publication Critical patent/NO20042061L/no
Publication of NO327966B1 publication Critical patent/NO327966B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oppfinnelsen tilveiebringer et FSH-preparat med en høy sialyseringsgrad og som viser økt virkeevne.
NO20042061A 2001-10-22 2004-05-18 Farmasoytisk preparat omfattende rekombinant FSH, anvendelse av rekombinant FSH, samt fremgangsmate for fremstilling av rekombinant FSH preparat. NO327966B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33808801P 2001-10-22 2001-10-22
PCT/EP2002/011501 WO2003035686A2 (en) 2001-10-22 2002-10-15 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments

Publications (2)

Publication Number Publication Date
NO20042061L true NO20042061L (no) 2004-07-13
NO327966B1 NO327966B1 (no) 2009-11-02

Family

ID=23323355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042061A NO327966B1 (no) 2001-10-22 2004-05-18 Farmasoytisk preparat omfattende rekombinant FSH, anvendelse av rekombinant FSH, samt fremgangsmate for fremstilling av rekombinant FSH preparat.

Country Status (24)

Country Link
US (1) US20050085412A1 (no)
EP (2) EP1621549A3 (no)
JP (1) JP2005515974A (no)
KR (1) KR100929971B1 (no)
CN (1) CN1608078B (no)
AR (1) AR036926A1 (no)
AT (1) ATE329930T1 (no)
AU (1) AU2002340562B2 (no)
CA (1) CA2464368A1 (no)
DE (1) DE60212425T2 (no)
DK (1) DK1438336T3 (no)
EA (1) EA007030B1 (no)
ES (1) ES2261740T3 (no)
HR (1) HRP20040278B1 (no)
IL (2) IL161235A0 (no)
ME (1) MEP38608A (no)
MX (1) MXPA04003352A (no)
NO (1) NO327966B1 (no)
PL (1) PL369606A1 (no)
PT (1) PT1438336E (no)
RS (1) RS32804A (no)
UA (1) UA87433C2 (no)
WO (1) WO2003035686A2 (no)
ZA (1) ZA200402279B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
EP2428225A3 (en) * 2006-09-10 2012-05-09 Glycotope GmbH Use of human cells of myeloid leukaemia origin for expression of antibodies
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
BRPI0815324A2 (pt) 2007-08-20 2015-07-14 Protalix Ltd "conjugado protêico que contém sacarídeos, processo de separação do conjugado protêico que contém sacarídeos, composição farmacêutica do conjugado protêico que contém sacarídeos, uso do conjugado protêico que contém sacarídeos e composto do conjugado protêico que contém sacarídeos"
TWI488640B (zh) * 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
JP2012524628A (ja) * 2009-04-22 2012-10-18 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 精巣の機能及び疾患の診断のためのｉｎｖｉｖｏでの１Ｈ磁気共鳴分光法
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
US9194011B2 (en) 2009-11-17 2015-11-24 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
CN102464713A (zh) * 2010-12-21 2012-05-23 上海丽珠制药有限公司 一种卵泡刺激素的制备方法
BR112013018516B1 (pt) 2011-01-20 2023-11-07 Protalix Ltd Construto de expressão de ácido nucleico, método de produção de uma proteína alfa-galactosidase humana recombinante, proteína alfagalactosidase humana, composição farmacêutica, e, uso de uma proteína alfagalactosidase humana ou de uma composição
CN103619358B (zh) 2011-03-31 2017-02-15 辉凌公司 药物制剂
WO2012168680A1 (en) * 2011-06-06 2012-12-13 Ferring B.V. Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
SG11201608132UA (en) 2014-04-18 2016-11-29 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
HUE067382T2 (hu) 2018-05-18 2024-10-28 Daiichi Sankyo Co Ltd Anti-MUC1-exatecan antitest-hatóanyag konjugátum

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1057895B (it) * 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
US5834251A (en) * 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
ES2218806T3 (es) * 1997-01-16 2004-11-16 Neose Technologies, Inc. Sialilacion practica in vitro de glicoproteinas recombinantes.
IL141063A (en) * 1998-08-07 2005-06-19 Applied Research Systems Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility
WO2000024755A1 (en) * 1998-10-28 2000-05-04 Baylor College Of Medicine Ovary-specific genes and proteins
DE60032349T2 (de) * 1999-04-26 2007-07-12 Genentech, Inc., South San Francisco Zellenzuchtverfahren für glycoproteine
JP2001299362A (ja) * 1999-12-17 2001-10-30 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones

Also Published As

Publication number Publication date
HRP20040278B1 (hr) 2008-03-31
US20050085412A1 (en) 2005-04-21
ES2261740T3 (es) 2006-11-16
WO2003035686A3 (en) 2003-10-09
CA2464368A1 (en) 2003-05-01
EP1438336A2 (en) 2004-07-21
NO327966B1 (no) 2009-11-02
AU2002340562B2 (en) 2008-10-23
CN1608078B (zh) 2012-07-25
UA87433C2 (ru) 2009-07-27
MEP38608A (en) 2011-02-10
EA200400574A1 (ru) 2004-08-26
ATE329930T1 (de) 2006-07-15
HRP20040278A2 (en) 2005-04-30
KR20040045885A (ko) 2004-06-02
DK1438336T3 (da) 2006-10-02
JP2005515974A (ja) 2005-06-02
IL161235A0 (en) 2004-09-27
DE60212425T2 (de) 2006-11-09
EP1621549A3 (en) 2006-03-01
EP1621549A2 (en) 2006-02-01
AR036926A1 (es) 2004-10-13
CN1608078A (zh) 2005-04-20
EA007030B1 (ru) 2006-06-30
PT1438336E (pt) 2006-08-31
MXPA04003352A (es) 2004-07-08
IL161235A (en) 2009-07-20
DE60212425D1 (de) 2006-07-27
PL369606A1 (en) 2005-05-02
ZA200402279B (en) 2005-10-26
RS32804A (sr) 2007-02-05
WO2003035686A2 (en) 2003-05-01
EP1438336B1 (en) 2006-06-14
KR100929971B1 (ko) 2009-12-04

Similar Documents

Publication Publication Date Title
NO20042061L (no) Gonadotropiner for folliculogenesis
EP1208085A4 (en) BENZANILIDE AS THE OPENER OF THE POTASSIUM CHANNEL
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
MY138074A (en) Somatostatin analogues
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
TW511649U (en) Wafer retainer
NO20053115L (no) Fremgangsmate for fremstilling av 2'-forgrenede nukleosider.
ATE374822T1 (de) Mutanter apre promoter
BR0306905A (pt) Vacinas de flavivìrus
MY129141A (en) Preparations of a sulfinyl acetamide
CY1107759T1 (el) Λυοφιλισμενη συνταγοποιηση που περιλαμβανει ολανζαπινη
ITRM20020105A0 (it) Dispersione poliuretanica con elevata durezza della pellicola, procedimento per la sua preparazione e suo impiego.
AU148078S (en) Bottle
ATE419268T1 (de) Haemasterlin analoge
ITMI20021822A1 (it) Manicotto elastico e procedimento per la fabbricazione di un manicotto elastico
WO2003092632A3 (en) Cyclic peptide anti-cancer agents and methods
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
WO2003092631A3 (en) Cyclic peptide anti-viral agents and methods
AU148415S (en) Bottle
SG185137A1 (en) Biologically active peptides
TR200000903T2 (tr) Romatizmal arteritlerin tedavisine yönelik yöntem ve kompozisyonlar.
AU3818001A (en) Selective n-acylation of a82846 glycopeptide analogs
AU2002233839A1 (en) Peptide fragments, derived from human telomerase reverse transcriptase
DE50212676D1 (de) Exopolysaccharidproduktion

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MM1K Lapsed by not paying the annual fees